These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 6325491

  • 1. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG, McGlohn MS.
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [Abstract] [Full Text] [Related]

  • 2. Comparative activity in different media of ketoconazole, miconazole and amphotericin B against Candida lusitaniae and sucrose-negative Candida tropicalis.
    Mignini F, Prenna M, Oliveri S, Cammarata E, Falcioni E, Dainelli B, Ripa S.
    Chemioterapia; 1988 Feb; 7(1):38-41. PubMed ID: 3378274
    [Abstract] [Full Text] [Related]

  • 3. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC.
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [Abstract] [Full Text] [Related]

  • 4. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E, Parras P, Lozano MC.
    Chemotherapy; 1992 Nov; 38(5):335-9. PubMed ID: 1337508
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G, Manzara S, Dettori G.
    Chemotherapy; 1991 Nov; 37(1):23-31. PubMed ID: 2013239
    [Abstract] [Full Text] [Related]

  • 6. Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
    Radetsky M, Wheeler RC, Roe MH, Todd JK.
    J Clin Microbiol; 1986 Oct; 24(4):600-6. PubMed ID: 3771749
    [Abstract] [Full Text] [Related]

  • 7. The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    Turnidge JD, Gudmundsson S, Vogelman B, Craig WA.
    J Antimicrob Chemother; 1994 Jul; 34(1):83-92. PubMed ID: 7961219
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents.
    Pfaller MA, Wey S, Gerarden T, Houston A, Wenzel RP.
    Diagn Microbiol Infect Dis; 1989 Jul; 12(1):1-4. PubMed ID: 2714066
    [Abstract] [Full Text] [Related]

  • 9. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
    Doern GV, Tubert TA, Chapin K, Rinaldi MG.
    J Clin Microbiol; 1986 Oct; 24(4):507-11. PubMed ID: 3533974
    [Abstract] [Full Text] [Related]

  • 10. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
    Still JM, Law EJ, Belcher KE, Spencer SA.
    Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents.
    Ohkawa M, Tokunaga S, Takashima M, Nishikawa T, Hisazumi H, Fujita S, Wheat RW.
    Chemotherapy; 1990 May; 36(6):396-402. PubMed ID: 2292203
    [Abstract] [Full Text] [Related]

  • 12. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M, de Montclos H, Flandrois JP.
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL, Monroy E, Negrete E, Vaca S.
    Rev Latinoam Microbiol; 2002 May; 44(2):65-8. PubMed ID: 17063773
    [Abstract] [Full Text] [Related]

  • 14. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ, Edwards JE, Guze LB.
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Hernández Molina JM, Llosá J, Martinez Brocal A, Ventosa A.
    Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
    [Abstract] [Full Text] [Related]

  • 16. In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
    Barchiesi F, Tortorano AM, Di Francesco LF, Cogliati M, Scalise G, Viviani MA.
    J Antimicrob Chemother; 1999 Feb; 43(2):295-9. PubMed ID: 11252339
    [Abstract] [Full Text] [Related]

  • 17. The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media.
    Siau H, Kerridge D.
    J Antimicrob Chemother; 1998 Mar; 41(3):357-66. PubMed ID: 9578162
    [Abstract] [Full Text] [Related]

  • 18. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA, Motley M, Warnock DW, Morrison CJ.
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [Abstract] [Full Text] [Related]

  • 20. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
    Ohta C, Yamane N, Nakasone I, Onaga S, Nakamura K.
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005 Dec; 16(2):127-33. PubMed ID: 16536058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.